• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交错质子栅格治疗 - 线性能量传递和相对生物学效应分布。

Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.

机构信息

Medical Radiation Physics, Department of Physics, Stockholm University, Stockholm, Sweden.

Medical Radiation Physics, Department of Physics, Stockholm University, Stockholm, Sweden; RaySearch Laboratories AB, Stockholm, Sweden.

出版信息

Phys Med. 2018 Dec;56:81-89. doi: 10.1016/j.ejmp.2018.10.025. Epub 2018 Nov 22.

DOI:10.1016/j.ejmp.2018.10.025
PMID:30473384
Abstract

PURPOSE

Interlaced beams have previously been proposed for delivering proton grid therapy. This study aims to assess dose-averaged LET (LET) and RBE-weighted dose (D) distributions of such beam geometries, and compare them with conventional intensity modulated proton therapy (IMPT).

METHODS

IMPT plans and four different interlaced proton grid therapy plans were generated for five patient cases (esophagus, lung, liver, prostate, anus). The constant RBE = 1.1 was assumed for optimization. The LET was subsequently Monte Carlo calculated for each plan and used as input for two LET-dependent variable RBE models. The fulfilment of clinical goals, along with DVH and spatial distribution evaluations, were then assessed and compared.

RESULTS

All plans fulfilled the clinical target goals assuming RBE = 1.1. The target coverage was slightly compromised for some grid plans when assuming the variable RBE models. All IMPT plans, and 18 of 20 grid plans, fulfilled all clinical goals for the organs at risk when assuming RBE = 1.1, whereas most plans failed at least one goal when assuming the variable RBE models. Compared with the IMPT plans, the grid plans demonstrated substantially different LET distributions due to the fundamentally different beam geometries. However, D distributions in the target were similar.

CONCLUSIONS

Despite the unconventional beam geometries of interlaced proton grid plans, with resulting alternating dose and LET patterns, the fulfillment of realistic clinical goals seems to be comparable to regular IMPT plans, both assuming RBE = 1.1 and variable RBE models. In addition, the alternating grid patterns do not seem to give rise to unexpected D hot-spots.

摘要

目的

交错射束先前已被提议用于递送质子栅格治疗。本研究旨在评估此类射束几何形状的剂量平均线性能量传递(LET)和重加权剂量(D)分布,并将其与常规强度调制质子治疗(IMPT)进行比较。

方法

为五个患者病例(食管、肺、肝、前列腺、肛门)生成了 IMPT 计划和四个不同的交错质子栅格治疗计划。假设恒定 RBE=1.1 进行优化。随后,对每个计划进行了蒙特卡罗计算以获得 LET,并将其用作两个依赖 LET 的可变 RBE 模型的输入。然后评估和比较了满足临床目标以及剂量体积直方图(DVH)和空间分布评估的情况。

结果

当假设 RBE=1.1 时,所有计划都满足了临床靶区目标。当假设可变 RBE 模型时,对于一些栅格计划,靶区覆盖略有受损。当假设 RBE=1.1 时,所有 IMPT 计划和 20 个栅格计划中的 18 个都满足了危及器官的所有临床目标,而当假设可变 RBE 模型时,大多数计划至少有一个目标失败。与 IMPT 计划相比,由于基本不同的射束几何形状,栅格计划显示出截然不同的 LET 分布。然而,靶区内的 D 分布相似。

结论

尽管交错质子栅格计划具有非常规的射束几何形状,导致剂量和 LET 交替模式,但在假设 RBE=1.1 和可变 RBE 模型的情况下,实现现实临床目标似乎与常规 IMPT 计划相当。此外,交替栅格模式似乎不会导致意外的 D 热点。

相似文献

1
Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.交错质子栅格治疗 - 线性能量传递和相对生物学效应分布。
Phys Med. 2018 Dec;56:81-89. doi: 10.1016/j.ejmp.2018.10.025. Epub 2018 Nov 22.
2
Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.在调强质子治疗优化中引入质子射程末端目标以降低关键结构中的线性能量传递和相对生物效应。
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):747-757. doi: 10.1016/j.ijrobp.2018.10.031. Epub 2018 Nov 2.
3
Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.颅内肿瘤质子治疗后与疑似治疗相关毒性相关的线性能量传递和相对生物效应的空间相关性。
Med Phys. 2020 Feb;47(2):342-351. doi: 10.1002/mp.13911. Epub 2019 Dec 4.
4
Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.在前列腺放射治疗的各种分割方案中,将可变的相对生物效应(RBE)纳入质子和光子计划比较中。
Med Phys. 2017 Mar;44(3):810-822. doi: 10.1002/mp.12117.
5
Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.网格大小对XiO脑癌治疗计划系统中均匀扫描和调强质子治疗计划的影响。
J Appl Clin Med Phys. 2015 Sep 8;16(5):447–456. doi: 10.1120/jacmp.v16i5.5510.
6
Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.我们能否推进前列腺质子治疗?在与调强放射治疗比较时,考虑替代射束角度和相对生物学效应的变化。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):454-464. doi: 10.1016/j.ijrobp.2016.01.018. Epub 2016 Jan 19.
7
Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.评估调强质子治疗相对于被动散射质子治疗在增加生长发育期儿科患者颅脊髓照射中对脊柱的保护作用。
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):37-46. doi: 10.1016/j.ijrobp.2017.01.226. Epub 2017 Feb 1.
8
Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?调强质子治疗与散射式质子治疗相比,线性能量传递的差异(即相对生物效应的差异)是否会影响调强质子治疗的剂量学优势?
Acta Oncol. 2018 Sep;57(9):1259-1264. doi: 10.1080/0284186X.2018.1468090. Epub 2018 May 4.
9
Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.基于 LET 的生物剂量在 IMPT 优化技术中的差异:稳健性和基于 PTV 的优化。
J Appl Clin Med Phys. 2020 Apr;21(4):42-50. doi: 10.1002/acm2.12844. Epub 2020 Mar 9.
10
Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.多束射束对肺癌调强质子治疗的计划质量、线性能量传递分布及计划稳健性的影响
ACS Sens. 2021 Feb 26;6(2):408-417. doi: 10.1021/acssensors.0c01879. Epub 2020 Oct 30.

引用本文的文献

1
Ensemble RBE Modeling in Proton Therapy: A Meta-Synthesis Framework for Dose Assessment in the Brainstem and Spinal Cord.质子治疗中的集成相对生物效应建模:脑干和脊髓剂量评估的元综合框架
Cancer Control. 2025 Jan-Dec;32:10732748251355396. doi: 10.1177/10732748251355396. Epub 2025 Jul 1.
2
Beyond a constant proton relative biological effectiveness: A survey of clinical and research perspectives among proton institutions in Europe and the United States.超越恒定的质子相对生物效应:欧美质子治疗机构的临床与研究视角调查
J Appl Clin Med Phys. 2025 Jan;26(1):e14535. doi: 10.1002/acm2.14535. Epub 2024 Nov 3.
3
Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival.
基于克隆形成细胞存活计算,通过交错和肿瘤剂量不均匀来优化质子微束放疗。
Sci Rep. 2021 Feb 11;11(1):3533. doi: 10.1038/s41598-021-81708-4.